In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

Sickle cell patients are fighting to save a specialist NHS unit they rely on during pain crises, warning that A&E delays and ...

After 35 years of consistent pain, Allan Byamukama became one of the few individuals in the world cured of sickle cell ...

Health officials said the decision was taken to use tribal languages after facing challenges in communicating health messages in the remote tribal belts.

The Sickle Cell Day Unit at the Royal London Hospital in Whitechapel, London, remains under threat following a temporary six-month trial, prompting sustained opposition from patients, families, and ...

The lifelong effects of rare blood disorder diagnoses in childhood are being analysed in a first-of-its-kind study led by the ...

When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was ...

US based cooking expert Yewande Komolafe tells the story of her battle with sickle cell and recounts her journey back to ...

The United Kingdom's Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists ...

What you need to know: Sickle cell disease (SCD) remains one of Uganda’s most silent epidemics, affecting thousands of children across the country, yet its impact is often underreported and ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance ...